111 related articles for article (PubMed ID: 22664934)
1. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.
Böhm D; Keller K; Pieter J; Boehm N; Wolters D; Siggelkow W; Lebrecht A; Schmidt M; Kölbl H; Pfeiffer N; Grus FH
Oncol Rep; 2012 Aug; 28(2):429-38. PubMed ID: 22664934
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
[TBL] [Abstract][Full Text] [Related]
3. Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer.
Akkour K; Alanazi IO; Alfadda AA; Masood A; Alhalal H; Joy SS; Bassi A; Alshehri E; Alwehaibi MA; Arafah M; Benabdelkamel H
BMC Cancer; 2024 Jun; 24(1):752. PubMed ID: 38902713
[TBL] [Abstract][Full Text] [Related]
4. Knowledge of Non-Invasive Biomarkers of Breast Cancer, Risk Factors, and BSE Practices Among Nursing Undergraduates in Farasan Island, KSA.
Sayed SF; Dailah HG; Nagarajan S; Abdelwahab SI; Abadi SSH; Akhtar N; Khuwaja G; Malham WAD
SAGE Open Nurs; 2024; 10():23779608241248519. PubMed ID: 38681865
[TBL] [Abstract][Full Text] [Related]
5. Oculomics: A Crusade Against the Four Horsemen of Chronic Disease.
Patterson EJ; Bounds AD; Wagner SK; Kadri-Langford R; Taylor R; Daly D
Ophthalmol Ther; 2024 Jun; 13(6):1427-1451. PubMed ID: 38630354
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Intraday Variations in the Tear Fluid Proteome.
Jones G; Altman J; Ahmed S; Lee TJ; Zhi W; Sharma S; Sharma A
Invest Ophthalmol Vis Sci; 2024 Mar; 65(3):2. PubMed ID: 38441890
[TBL] [Abstract][Full Text] [Related]
7. Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges.
Diaz PM; Leehans A; Ravishankar P; Daily A
Biomark Insights; 2023; 18():11772719231204508. PubMed ID: 37846373
[TBL] [Abstract][Full Text] [Related]
8. Biomarker Reproducibility Challenge: A Review of Non-Nucleotide Biomarker Discovery Protocols from Body Fluids in Breast Cancer Diagnosis.
Safari F; Kehelpannala C; Safarchi A; Batarseh AM; Vafaee F
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345117
[TBL] [Abstract][Full Text] [Related]
9. Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype.
Neagu AN; Whitham D; Seymour L; Haaker N; Pelkey I; Darie CC
Proteomes; 2023 Apr; 11(2):. PubMed ID: 37092454
[TBL] [Abstract][Full Text] [Related]
10. Emerging Applications of Electrochemical Impedance Spectroscopy in Tear Film Analysis.
Ozdalgic B; Gul M; Uygun ZO; Atçeken N; Tasoglu S
Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36290964
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a short-term breast health measure as a supplement to screening mammography.
Daily A; Ravishankar P; Wang W; Krone R; Harms S; Klimberg VS
Biomark Res; 2022 Oct; 10(1):76. PubMed ID: 36284356
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer.
Neagu AN; Jayathirtha M; Whitham D; Mutsengi P; Sullivan I; Petre BA; Darie CC
Proteomes; 2022 Oct; 10(4):. PubMed ID: 36278695
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence Sensing Technologies for Ophthalmic Diagnosis.
Shi Y; Hu Y; Jiang N; Yetisen AK
ACS Sens; 2022 Jun; 7(6):1615-1633. PubMed ID: 35640088
[TBL] [Abstract][Full Text] [Related]
14. Identification of Endogenous Peptides in Nasal Swab Transport Media used in MALDI-TOF-MS Based COVID-19 Screening.
Tsai H; Phinney BS; Grigorean G; Salemi MR; Rashidi HH; Pepper J; Tran NK
ACS Omega; 2022 May; 7(20):17462-17471. PubMed ID: 35600141
[TBL] [Abstract][Full Text] [Related]
15. Using tears as a non-invasive source for early detection of breast cancer.
Daily A; Ravishankar P; Harms S; Klimberg VS
PLoS One; 2022; 17(4):e0267676. PubMed ID: 35471994
[TBL] [Abstract][Full Text] [Related]
16. The future of early cancer detection.
Fitzgerald RC; Antoniou AC; Fruk L; Rosenfeld N
Nat Med; 2022 Apr; 28(4):666-677. PubMed ID: 35440720
[TBL] [Abstract][Full Text] [Related]
17. A Meta-Analysis of Wearable Contact Lenses for Medical Applications: Role of Electrospun Fiber for Drug Delivery.
Hosseinian H; Hosseini S; Martinez-Chapa SO; Sher M
Polymers (Basel); 2022 Jan; 14(1):. PubMed ID: 35012207
[TBL] [Abstract][Full Text] [Related]
18. The potential of tear proteomics for diagnosis and management of orbital inflammatory disorders including Graves' ophthalmopathy.
Khazaei H; Khazaei D; Verma R; Ng J; Wilmarth PA; David LL; Rosenbaum JT
Exp Eye Res; 2021 Dec; 213():108813. PubMed ID: 34742692
[TBL] [Abstract][Full Text] [Related]
19. Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics.
Ferrara F; Zoupanou S; Primiceri E; Ali Z; Chiriacò MS
Biosens Bioelectron; 2022 Jan; 196():113698. PubMed ID: 34688113
[TBL] [Abstract][Full Text] [Related]
20. Proteomics and its applications in breast cancer.
Neagu AN; Whitham D; Buonanno E; Jenkins A; Alexa-Stratulat T; Tamba BI; Darie CC
Am J Cancer Res; 2021; 11(9):4006-4049. PubMed ID: 34659875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
